COMMUNIQUÉS West-GlobeNewswire

Voyager Therapeutics Announces Closing of Public Offering of Common Stock
10/11/2017
CAMBRIDGE, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]
MediWound to Host Third Quarter 2017 Financial Results Conference Call on November 16, 2017 at 8:30 a.m. Eastern Time
10/11/2017
YAVNE, Israel, Nov. 10, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD ), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound [...]
Five Prime Therapeutics Presents Poster on FGFR2b Expression and Immune Signature in Urothelial Cancer at the Society for Immunotherapy of Cancer 32nd Annual Meeting
10/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]
Dr. Ramzan Zakir Elected to the American Health Council’s Board of Physicians
10/11/2017
NEW YORK, Nov. 10, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to elect Dr. Ramzan Zakir, current Clinical Assistant Professor of Medicine at Heart and Vascular Institute of Central New Jersey, to [...]
Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association North Central Section Annual Meeting in Scottsdale AZ November 15
10/11/2017
HASBROUCK HEIGHTS, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to report that a Symposium on Fexapotide Triflutate studies will be held at the Annual Meeting of [...]
Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference
10/11/2017
PLYMOUTH MEETING, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that two of its cancer immunotherapies demonstrated antigen-specific T-cell stimulation in phase 1 [...]
Progressive Care Announces Third Quarter Conference Call and Webcast with Investors on November 14, 2017
10/11/2017
MIAMI, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]
eFFECTOR Therapeutics Presents Preclinical Data for eFT508 that Demonstrates Beneficial Immunological Effects
10/11/2017
SAN DIEGO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced a poster presentation of [...]
RavenQuest Announces Formal Agreement With Western Agripharma Limited
10/11/2017
VANCOUVER, British Columbia, Nov. 10, 2017 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has entered into an agreement with Western Agripharma Limited [...]
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%
10/11/2017
BUENA, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
OrthoPediatrics Corp. to Present at Stifel 2017 Healthcare Conference
10/11/2017
WARSAW, Ind., Nov. 10, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark [...]
Oxford Immunotec to Present at the Jefferies 2017 London Healthcare Conference
10/11/2017
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company focused on developing and commercializing [...]
Adaptimmune Presents Study Designs for Ongoing MAGE-A4 and NY-ESO SPEAR T-cell Clinical Trials at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
10/11/2017
PHILADELPHIA and OXFORD, U.K., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, is presenting two trials in progress posters summarizing study [...]
Vilacto Bio Inc. in final stage of developing Anti-Aging Products
10/11/2017
COPENHAGEN, Denmark, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI), announces that it is in the final stage of developing its new anti-aging skin care line. The company is extremely hopeful with the [...]
Dova Pharmaceuticals to Present at Jefferies 2017 London Healthcare Conference
10/11/2017
DURHAM, N.C., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Jefferies 2017 [...]
Kamada Announces Nomination of Three New Members to its Board of Directors
10/11/2017
REHOVOT, Israel, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company focused on orphan indications, announced today that the Company Board of [...]
Aduro Biotech Announces Promising Preclinical Data that Validate Anti-CTLA-4 Antibody ADU-1604
10/11/2017
BERKELEY, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today announced data from preclinical studies with ADU [...]
Prophase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common Stock
10/11/2017
DOYLESTOWN, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (the “Company” or “ProPhase”), today announced that [...]
Galen Partners Completes Sale of Cambrooke Therapeutics
10/11/2017
STAMFORD, Conn., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Galen Partners, a healthcare-focused, growth equity investment firm, announced today the sale of Cambrooke Therapeutics, Inc. (“Cambrooke”) to Ajinomoto Co. Cambrooke [...]

Pages